Titan Biotech Limited

BOM-524717
Bombay Stock Exchange
Biological Products, Except Diagnostic Substances
Global Rank
#31133
Country Rank
#2045
Market Cap
40.47 M
Price
4.9
Change (%)
0.75%
Volume
2,842

BOM-524717's Next Dividend

Next Estimated Amount
₹2.41
Next Estimated Pay Date
11/01/2025
Last Amount
₹2
Last Pay Date
10/30/2024
Dividend Shot Clock Ex-Date: 09/23/2024
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Titan Biotech Limited Dividend Chart

*Amounts are shown in the stock exchange currency (INR) for convenience

Titan Biotech Limited(BOM-524717) Dividend History

Titan Biotech Limited (BOM-524717) currently pays an annual dividend of $2.00 per share, offering a dividend yield of 0.47%. The next dividend payout date has not been announced. With 2 consecutive years of dividend growth, Titan Biotech Limited has steadily increased its payout at an average annual rate of 11.11%, demonstrating a consistent commitment to rewarding investors.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2024 ₹2 11%
09/23/2024 ₹2 09/23/2024 10/30/2024 11%
2023 ₹1.8 20%
09/22/2023 ₹1.8 09/22/2023 10/29/2023 20%
2022 ₹1.5 0%
09/22/2022 ₹1.5 09/23/2022 10/30/2022 0%
2021 ₹1.5 50%
09/16/2021 ₹1.5 09/17/2021 10/24/2021 50%
2020 ₹1
09/17/2020 ₹1 09/18/2020 10/25/2020
*Amounts are shown in the stock exchange currency (INR) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.